A, T., D, C., Y, A., J, G., R, S., L, H., . . . P, V. (2026). Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered. Acta neuropathologica communications, 14(1), . https://doi.org/10.1186/s40478-026-02293-z
Chicago Style (17th ed.) CitationA, Tauziède-Espariat, et al. "Usefulness OF SOX10 Immunohistochemistry for Subtyping Diffuse Midline Gliomas EGFR-altered." Acta Neuropathologica Communications 14, no. 1 (2026). https://doi.org/10.1186/s40478-026-02293-z.
MLA (9th ed.) CitationA, Tauziède-Espariat, et al. "Usefulness OF SOX10 Immunohistochemistry for Subtyping Diffuse Midline Gliomas EGFR-altered." Acta Neuropathologica Communications, vol. 14, no. 1, 2026, https://doi.org/10.1186/s40478-026-02293-z.